{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T20:56:31Z","timestamp":1792356991605,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/maj.0b013e3182514059","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T23:45:46Z","timestamp":1335397546000},"page":"364-366","source":"Crossref","is-referenced-by-count":48,"title":["Management of Comorbidities in Ankylosing Spondylitis"],"prefix":"10.1016","volume":"343","author":[{"given":"James","family":"Rosenbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e3182514059_bb0005","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/acr.20408","article-title":"Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis","volume":"63","author":"Bremander","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0010","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/art.21197","article-title":"Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with antitumor necrosis factor agents infliximab and etanercept","volume":"52","author":"Braun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.berh.2006.03.010","article-title":"Ankylosing spondylitis and bowel disease","volume":"20","author":"Rudwaleit","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/gut.40.5.619","article-title":"Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease","volume":"40","author":"Evans","year":"1997","journal-title":"Gut"},{"issue":"suppl 1","key":"10.1097\/MAJ.0b013e3182514059_bb0025","first-page":"S2","article-title":"American College of Gastroenterology IBD Task Force","volume":"106","author":"Talley","year":"2011","journal-title":"An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.22669","article-title":"Differences in the incidence of flares or new onset inflammatory bowel disease in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents","volume":"57","author":"Braun","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/acr.20364","article-title":"Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis","volume":"63","author":"Mathieu","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/ard.2009.110593","article-title":"Ankylosing spondylitis: a risk factor for myocardial infarction?","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0045","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/ard.2008.100503","article-title":"Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study","volume":"68","author":"Vosse","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0050","first-page":"2273","article-title":"Canadian Rheumatology Association\/Spondyloarthritis Research Consortium of Canada","volume":"34","author":"Maksymowych","year":"2007","journal-title":"The Canadian Rheumatology Association\/Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder project. J Rheumatol"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.coph.2011.07.002","article-title":"NLRs in immune privileged sites","volume":"11","author":"Rosenzweig","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0060","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.4049\/jimmunol.0900138","article-title":"NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways","volume":"183","author":"Willingham","year":"2009","journal-title":"J Immunol"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0065","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/art.1780200714","article-title":"Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway complement","volume":"20","author":"Keystone","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/art.20777","article-title":"A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease","volume":"52","author":"Martin","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0075","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.4049\/jimmunol.155.5.2679","article-title":"A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB\/c mice","volume":"155","author":"Buz\u00e1s","year":"1995","journal-title":"J Immunol"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0080","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.23471","article-title":"Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept","volume":"58","author":"van der Heijde","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0085","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2006.04.038","article-title":"Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation","volume":"113","author":"Galor","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0090","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/art.23835","article-title":"Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action","volume":"59","author":"Collamer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e3182514059_bb0095","first-page":"767","article-title":"IFNg regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondyloarthritis","volume":"64","author":"Kezic","year":"2012","journal-title":"Arthritis Rehum"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915309654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915309654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T08:42:26Z","timestamp":1687423346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915309654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0002962915309654"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e3182514059","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}